李进-话题@MedSci

#李进#

4篇内容 | 1098人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2130450, encodeId=585d213045012, content=<a href='/topic/show?id=9b41614554a' target=_blank style='color:#2F92EE;'>#李进#</a>教授：<a href='/topic/show?id=de4d9343316' target=_blank style='color:#2F92EE;'>#转移性胃癌#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>进展, objectTitle=CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点, objectType=article, longId=768269, objectId=6b4be68269b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230411/5a2024f42a9e47b9b7ad9d60525d82f5.jpg, objectUrl=/article/show_article.do?id=6b4be68269b6, replyNumber=0, likeNumber=63, createdTime=2023-05-06, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b4be68269b6, moduleTitle=CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4be68269b6)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2130452, encodeId=21c82130452d8, content=<a href='/topic/show?id=dc29e50954f' target=_blank style='color:#2F92EE;'>#秦叔逵#</a>、<a href='/topic/show?id=9b41614554a' target=_blank style='color:#2F92EE;'>#李进#</a>教授发现<a href='/topic/show?id=3fca4e359e3' target=_blank style='color:#2F92EE;'>#尼妥珠单抗#</a>联合<a href='/topic/show?id=10dc3890e66' target=_blank style='color:#2F92EE;'>#吉西他滨#</a>可提高<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>患者疗效, objectTitle=ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效, objectType=article, longId=729412, objectId=4900e294125e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220608/60242e4ac3e24371bf3be83904cfc37c.jpg, objectUrl=/article/show_article.do?id=4900e294125e, replyNumber=0, likeNumber=81, createdTime=2023-05-06, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4900e294125e, moduleTitle=ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4900e294125e)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=895297, encodeId=880789529e56, content=<a href='/topic/show?id=9b41614554a' target=_blank style='color:#2F92EE;'>#李进#</a>, objectTitle=李进教授自述：有良心才能成为良医, objectType=article, longId=195817, objectId=fb6f19581e60, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200612/3e36d00f6d174cd1ab9fec94281c2f05.jpg, objectUrl=/article/show_article.do?id=fb6f19581e60, replyNumber=0, likeNumber=126, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6f19581e60, moduleTitle=李进教授自述：有良心才能成为良医, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6f19581e60)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=886745, encodeId=2ba3886e4510, content=<a href='/topic/show?id=f31f39333f0' target=_blank style='color:#2F92EE;'>#吴一龙#</a><a href='/topic/show?id=9b41614554a' target=_blank style='color:#2F92EE;'>#李进#</a>还是热门人物, objectTitle=CSCO 2020看点：最忙碌的PI是哪些，你都认识么？, objectType=article, longId=200951, objectId=df2e20095158, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200910/a627581e922f45cdab5f61c31d7e1b64.jpg, objectUrl=/article/show_article.do?id=df2e20095158, replyNumber=0, likeNumber=180, createdTime=2020-09-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2e20095158, moduleTitle=CSCO 2020看点：最忙碌的PI是哪些，你都认识么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2e20095158)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

李进

2020-05-29

(审核中...)

前往app查看评论内容

#李进#教授：#转移性胃癌##新药#进展

CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点

2023-05-06发表于上海

(审核中...)

前往app查看评论内容

#秦叔逵#、#李进#教授发现#尼妥珠单抗#联合#吉西他滨#可提高#胰腺癌#患者疗效

ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效

2023-05-06发表于上海

lovetcm (审核中...)

前往app查看评论内容

#李进#

李进教授自述：有良心才能成为良医

2020-10-29

lovetcm (审核中...)

前往app查看评论内容

#吴一龙##李进#还是热门人物

CSCO 2020看点：最忙碌的PI是哪些，你都认识么？

2020-09-19

科室
- - 订阅+
  - 更多科室
工具
服务